Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 6 (RPL32P6)
- Target
- RPL32P6
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L32 pseudogene 6 (RPL32P6) is a human processed pseudogene derived from the ribosomal protein L32 (RPL32) gene. While RPL32 is an essential structural protein of the 60S ribosomal subunit responsible for protein synthesis in cells[4][7], RPL32P6 itself does not encode a protein and is classed as a pseudogene[2][5]. Pseudogenes are often remnants from gene duplication events, and most do not contribute to coding capacity or biological activity, although research on other pseudogenes has shown occasional regulatory roles[8]. At present, RPL32P6 is not considered functionally relevant or a therapeutic target in biomedical science[2][5][9].
- Other names
- RPL32P6RPL32_1_26
02
Mechanism of action
None — As above, no drugs target this pseudogene.
03
Biological functions
Other — No established biological functions. Pseudogenes such as RPL32P6 typically have no known protein-coding or direct biological function, although other pseudogenes are sometimes involved in regulatory processes
04
Disease associations
None directly associated. While parental genes (like RPL32) may be associated with disease, there is currently no evidence linking RPL32P6 to disease roles
Beyond the preview
Go deeper on Ribosomal protein L32 pseudogene 6 (RPL32P6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 6 (RPL32P6).